Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: Consistent expression in papillary and chromophobe renal cell carcinomas

Human Pathology

Volumn 32, Issue 10, 2001, Pages 1071-1077

  Kuroda, Naoto ^a   Inoue, Keiji ^a   Guo, Limei ^a   Miyazaki, Eriko ^a   Hayashi, Yoshihiro ^a   Naruse, Keishi ^a   Toi, Makoto ^a   Hiroi, Makoto ^a   Shuin, Taro ^a   Enzan, Hideaki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

CD9 motility related protein 1; Renal cell carcinoma

Indexed keywords

CD9 ANTIGEN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; KIDNEY PARENCHYMA; MALE; ONCOCYTOMA; PAPILLARY CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034759159     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.28235     Document Type: Article

References (28)

1. Expression of a 26,000-dalton glycoprotein on activated human T cells
2. Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility
3. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA
4. Assignment of the human CD9 gene to chromosome 12 (region P13) by use of human specific DNA probes
5. Molecular cloning of the CD9 antigen. A new family of cell surface proteins
6. cDNA cloning and expression of platelet p24/CD9
7. Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb/IIIa complex
8. Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: Comparison with CD9, CD63, and α5β1 integrin
9. CD9, a major platelet cell surface glycoprotein, is a ROCA antigen and is expressed in the nervous system
10. Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (pro HB-EGF) to preserve renal epithelial cell viability
11. Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma
12. Motility related protein 1 (MRP-1/CD9) expression: Inverse correlation with metastasis in breast cancer
13. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer
14. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer
15. Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells
16. Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis
17. Motility related protein 1 (MRP1/CD9) expression in colon cancer
18. Correlation of reduction in MRP-1/CD9 and KA1/CD82 expression with recurrences in breast cancer patients
19. Classification of renal cell carcinoma. Workgroup No. 1
20. Prognostic significance of morphologic parameters in renal cell carcinoma
21. The results of radical nephrectomy for renal cell carcinoma
22. Sialylated glycoconjugates in chromophobe cell renal carcinoma compared with other renal cell tumors. Identification of its development from the collecting duct epithelium
23. Papillary (chromophil) renal cell carcinoma: Histologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases
24. Chromophobe cell renal carcinoma and its variant - A report of 32 cases
25. Chromophobe cell renal carcinoma: Clinicopathological features of 50 cases
26. Renal oncocytoma: A reappraisal of morphologic features with clinicopathologic findings in 80 cases
27. Collecting duct carcinoma of the kidney
28. Collecting duct carcinoma of the kidney